Thyrocare Technologies Ltd Incorporated in 2000, Thyrocare Technologies Ltd is one of the leading pan-India diagnostic chains and conducts an array of medical diagnostic tests and profiles of tests that helps in early detection and management of disorders and diseases.
They are India's first fully automated diagnostic laboratory having its strong presence in more than 2000 cities / towns in India and internationally. As of November 30, 2015, they offered 192 tests and 54 profiles of tests to detect a number of disorders, including thyroid disorders, growth disorders, metabolism disorders, auto-immunity, diabetes, anemia, cardiovascular disorders, infertility and various infectious diseases.
Their laboratory process over 30,000 sample and above 1 lakh investigations every day. Their profiles of tests include 17 profiles of tests administered under their 'Aarogyam' brand. Through wholly owned subsidiary, NHL, they operate a network of molecular imaging centers in New Delhi, Navi Mumbai and Hyderabad, focused on early and effective cancer monitoring.
The promoters of the company are:
1. Dr A. Velumani
2. Mr A. Sundararaju
Objects of the Issue:
The object of the issue is to:
1. Achieve the benefits of listing the Equity Shares on the BSE and the NSE; and
2. Carry out the sale of up to 10,744,708 Equity Shares by the Selling Shareholders.
»» Issue Open: Apr 27, 2016 – Apr 29, 2016
»» Issue Type: 100% Book Built Issue IPO
»» Issue Size: 10,744,708 Equity Shares of Rs. 10
»» Issue Size: Rs. [.] Crore
»» Face Value: Rs. 10 Per Equity Share
»» Issue Price: Rs. – Rs. Per Equity Share
»» Market Lot:
»» Minimum Order Quantity:
»» Listing At: BSE, NSE